Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. - Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; et al. (Genome medicine, 2020)